Histidine- and glycine-functionalized cerium oxide nanoparticles: Physicochemical properties and antiviral activity
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications · Advanced biosensing and bioanalysis techniques
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (73)
Show source-provided references
1. Diverse gatekeepers for mesoporous silica nanoparticle based drug delivery systems10.1039/C7CS00219J ↗
2. Supramolecular metal-based nanoparticles for drug delivery and cancer therapy10.1016/j.cbpa.2021.01.005 ↗
3. Hyaluronic acid and albumin based nanoparticles for drug delivery10.1016/j.jconrel.2021.01.033 ↗
4. Cerium oxide nanoparticle-loaded polyvinyl alcohol nanogels delivery for wound healing care systems on surgery10.1080/10717544.2020.1858998 ↗
5. Targeted delivery and redox activity of folic acid-functionalized nanoceria in tumor cells10.1021/acs.molpharmaceut.7b00920 ↗
6. Catalytic nanomaterials toward atomic levels for biomedical applications: from metal clusters to single-atom catalysts10.1021/acsnano.0c06962 ↗
7. Recent progress in time-resolved biosensing and bioimaging based on lanthanide-doped nanoparticles10.1002/smll.201804969 ↗
8. Bimetallic and multimetallic nanoparticles as nanozymes10.1016/j.snb.2021.129736 ↗
9. Molecule-gated surface chemistry of Pt nanoparticles for constructing activity-controllable nanozymes and a three-in-one sensor10.1039/C9AN01956A ↗
10. Advanced applications of cerium oxide based nanozymes in cancer10.1039/D1RA05407D ↗
11. Active targeting strategies using biological ligands for nanoparticle drug delivery systems10.3390/cancers11050640 ↗
12. The role of ligands in the chemical synthesis and applications of inorganic nanoparticles10.1021/acs.chemrev.8b00733 ↗
13. Histidine and arginine conjugated starch-PEI and its corresponding gold nanoparticles for gene delivery10.1016/j.ijbiomac.2018.08.142 ↗
14. A novel approach for combating klebsiella pneumoniae biofilm using histidine functionalized silver nanoparticles10.3389/fmicb.2017.01104 ↗
15. Studies on L-histidine capped Ag and Au nanoparticles for dopamine detection10.1016/j.msec.2016.11.102 ↗
16. Targeting of carbonic anhydrase IX-positive cancer cells by glycine-coated superparamagnetic nanoparticles10.1016/j.colsurfb.2021.111893 ↗
17. Ultrasonication mediated fabrication of glycine coated gadolinium oxide nanoparticles as MRI contrast agents10.1007/s10876-020-01836-1 ↗
18. Antioxidant and toxicity studies of biosynthesized cerium oxide nanoparticles in rats10.2147/IJN.S194192 ↗
19. Synthesis, stability, and cytotoxicity of novel cerium oxide nanoparticles for biomedical applications10.1007/s10876-020-01798-4 ↗
20. Anticancer therapeutic effect of cerium-based nanoparticles: known and unknown molecular mechanisms10.1039/D2BM00334A ↗
21. A.B. Shcherbakov, N.M. Zholobak, V.K. Ivanov, 8 - Biological, biomedical and pharmaceutical applications of cerium oxide, in: Cerium oxide (CeO₂): synthesis, properties and applications (Eds.), Met. Oxides, Elsevier, 2020: pp. 279–358, doi:10.1016/B978-0-12-815661-2.00008-6. https://www.sciencedirect.com/science/article/abs/pii/B9780128156612000086.10.1016/B978-0-12-815661-2.00008-6 ↗
22. Pharmacological potential of cerium oxide nanoparticles10.1039/c0nr00875c ↗
23. Cerium oxide nanoparticles: a new therapeutic tool in liver diseases10.3390/antiox10050660 ↗
24. Chapter 12 - Interaction of nanoceria with microorganisms
25. L.P. Babenko, N.M. Zholobak, A.B. Shcherbakov, S.I. Voychuk, L.M. Lazarenko, M.Y. Spivak, Antibacterial activity of cerium colloids against opportunistic microorganisms in vitro, Mikrobiol. Z. 74 (2012) 54–62, PMID:22830198. https://pubmed.ncbi.nlm.nih.gov/22830198/.
26. Synthesis, physicochemical characterization, antifungal activity and toxicological features of cerium oxide nanoparticles10.1016/j.arabjc.2020.10.035 ↗
27. N.M. Zholobak, Z.M. Olevinskaia, N.I. Spivak, A.B. Shcherbakov, V.K. Ivanov, A.V. Usatenko, Antiviral effect of cerium dioxide nanoparticles stabilized by low-molecular polyacrylic acid, Mikrobiolohichnyi Zhurnal (Ukraine). 72 (2010) 42–47, PMID: 20695228. https://pubmed.ncbi.nlm.nih.gov/20695228/.
28. Nanoparticles of cerium dioxide – an effective antiviral agent and adjuvant of biologically active molecules10.15587/2519-8025.2018.124686 ↗
29. Direct monitoring of the interaction between ROS and cerium dioxide nanoparticles in living cells10.1039/C4RA08292C ↗
30. Promising antiviral, antimicrobial and therapeutic properties of green nanoceria10.2217/nnm-2019-0368 ↗
31. Nanoceria as a possible agent for the management of COVID-1910.1016/j.nantod.2020.100982 ↗
32. Antiviral efficacy of cerium oxide nanoparticles10.1038/s41598-022-23465-6 ↗
33. Cerium dioxide nanoparticles increase immunogenicity of the influenza vaccine10.1016/j.antiviral.2015.12.013 ↗
34. Fusion of enveloped viruses in endosomes10.1111/tra.12389 ↗
35. Structures of vesicular stomatitis virus glycoprotein: membrane fusion revisited10.1007/s00018-008-7534-3 ↗
36. The role of histidine residues in low-pH-mediated viral membrane fusion10.1016/j.str.2006.07.011 ↗
37. Advances and prospects of using nanocrystalline ceria in cancer theranostics10.1134/S003602361413004X ↗
38. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells10.1016/j.virol.2005.05.006 ↗
39. Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxide nanoparticles10.1039/c0mb00014k ↗
40. Protein corona modulates uptake and toxicity of nanoceria via clathrin-mediated endocytosis10.1086/689590 ↗
41. Viral inactivation based on Inhibition of membrane fusion: understanding the role of histidine protonation to develop new viral vaccines10.2174/092986609788681823 ↗
42. Physical, chemical and electrochemical properties of pure and doped ceria10.1016/S0167-2738(99)00318-5 ↗
43. Bonding of histidine to cerium oxide10.1021/jp404385h ↗
44. Thermally controlled bonding of adenine to cerium oxide: effect of substrate stoichiometry, morphology, composition, and molecular deposition technique10.1021/acs.jpcc.7b06925 ↗
45. The MTT and crystal violet assays: potential confounders in nanoparticle toxicity testing10.1177/1091581816648906 ↗
46. The comparison of MTT and CVS assays for the assessment of anticancer agent interactions10.1371/journal.pone.0155772 ↗
47. Fehr · 2015 · 1
48. Cellular and viral requirements for rapid endocytic entry of herpes simplex virus10.1128/JVI.78.14.7508-7517.2004 ↗
49. Panthenol-stabilized cerium dioxide nanoparticles for cosmeceutic formulations against ROS-induced and UV-induced damage10.1016/j.jphotobiol.2013.10.015 ↗
50. Cerium oxide nanoparticles: Size-selective formation and structure analysis10.1063/1.1430502 ↗
51. Blue shift in ultraviolet absorption spectra of monodisperse CeO2−x nanoparticles10.1063/1.372016 ↗
52. S.V.N.T. Kuchibhatla, A.S. Karakoti, S. Thevuthasan, S. Seal, D.R. Baer, Influence of aging on the properties of cerium oxide nanoparticles - implications to quantum confinement effect, in: 11th IEEE Int. Conf. Nanotechnol., 2011: pp. 646–650, doi:10.1109/NANO.2011.6144639. https://ieeexplore.ieee.org/document/6144639.10.1109/NANO.2011.6144639 ↗
53. Strong quantum confinement effect in nanocrystalline cerium oxide10.1016/j.matlet.2011.05.022 ↗
54. Quantum confinement effect in high quality nanostructured CeO2 thin films10.1063/1.2841719 ↗
55. The Isoelectric Points of Solid Oxides, Solid Hydroxides, and Aqueous Hydroxo Complex Systems10.1021/cr60234a002 ↗
56. Cerium oxide stoichiometry alteration via Sn deposition: Influence of temperature10.1016/j.elspec.2008.10.003 ↗
57. Calculations of electron inelastic mean free paths (IMFPS). IV. Evaluation of calculated IMFPs and of the predictive IMFP formula TPP-2 for electron energies between 50 and 2000 eV10.1002/sia.740200112 ↗
58. Histidine adsorption on nanostructured cerium oxide10.1016/j.elspec.2016.07.005 ↗
59. Kosto · 2021
60. Functionalization of nanostructured cerium oxide films with histidine10.1039/C4CP03780D ↗
61. Role of the redox state of cerium oxide on glycine adsorption: an experimental and theoretical study10.1039/D2CP06068J ↗
62. Oxidation state and lattice expansion of CeO2-x nanoparticles as a function of particle size10.1103/PhysRevB.69.125415 ↗
63. Electron spectroscopy of single crystal and polycrystalline cerium oxide surfaces10.1016/S0039-6028(98)00257-X ↗
64. C. Zhang, T. Zhang, J. Zou, C.L. Miller, R. Gorkhali, J.-Y. Yang, A. Schilmiller, S. Wang, K. Huang, E.M. Brown, K.W. Moremen, J. Hu, J.J. Yang, Structural basis for regulation of human calcium-sensing receptor by magnesium ions and an unexpected tryptophan derivative co-agonist, Sci. Adv. 2 (2016) e1600241, doi: 10.1126/sciadv.1600241. https://www.science.org/doi/10.1126/sciadv.1600241.10.1126/sciadv.1600241 ↗
65. How the surface chemical properties of nanoceria are related to its enzyme-like, antiviral and degradation activity10.1039/D2EN00173J ↗
66. Metal-mediated nanoscale cerium oxide inactivates human coronavirus and rhinovirus by surface disruption10.1021/acsnano.1c04142 ↗
67. Herpes simplex virus gE/gI sorts nascent virions to epithelial cell junctions, promoting virus spread10.1128/JVI.75.2.821-833.2001 ↗
68. Histidine protonation and the activation of viral fusion proteins10.1042/BST0360043 ↗
69. Coronavirus membrane fusion mechanism offers a potential target for antiviral development10.1016/j.antiviral.2020.104792 ↗
70. Herpesvirus entry: an update10.1128/JVI.77.19.10179-10185.2003 ↗
71. Different effects of His-Au NCs and MES-Au NCs on the propagation of pseudorabies virus10.1002/gch2.201800030 ↗
72. Probing the interaction between vesicular stomatitis virus and phosphatidylserine10.1007/s00249-005-0012-z ↗
73. Membrane fusion induced by vesicular stomatitis virus depends on histidine protonation10.1074/jbc.M210615200 ↗